BAM15 Research Guide

Full name: BAM15 (Mitochondrial Uncoupler)

A next-generation mitochondrial protonophore ("uncoupler") researched as a metabolism-boosting fat-loss agent. Unlike the dangerous older uncoupler DNP, BAM15 shows a much wider safety margin in animals, drawing strong biohacker curiosity.

How BAM15 Works

Selectively transports protons across the inner mitochondrial membrane, dissipating the proton gradient as heat rather than ATP. Cells burn more substrate (fat and glucose) to maintain energy, increasing metabolic rate without stimulating the CNS.

Dosing Protocol

• Typical dose: Not established for humans
• Frequency: Research protocols only
• Duration: Experimental
• Route: Oral (research)

Reported Benefits

• Increases metabolic rate/energy expenditure
• Fat loss without appetite suppression
• Improved insulin sensitivity (animal models)
• Reduced liver fat
• Wider safety margin than DNP (preclinical)

Potential Side Effects

• Unknown human safety
• Potential overheating (uncoupler class)
• No approved human use
• Requires careful dose control
• Possible energy/fatigue changes

Research Citations

1. BAM15 reduces obesity without lowering food intake (2020) - Oral BAM15 decreased fat mass and improved insulin sensitivity in obese mice without reducing appetite or muscle.
2. BAM15 safety versus DNP (2018) - Showed a substantially wider therapeutic window than the classical uncoupler DNP in preclinical models.

Related Weight Management Compounds

• AOD-9604 - Full Profile
• Semaglutide - Full Profile
• Tirzepatide - Full Profile
• Retatrutide - Full Profile
• Tesofensine - Full Profile
• CagriSema - Full Profile

View full BAM15 profile with 3D molecule viewer →